W Burman

Summary

Affiliation: Denver Health Medical Center
Country: USA

Publications

  1. ncbi request reprint The effects of local review on informed consent documents from a multicenter clinical trials consortium
    William Burman
    Denver Public Health, 605 Bannock Street, Denver, CO 80204, USA
    Control Clin Trials 24:245-55. 2003
  2. ncbi request reprint Clinical and radiographic features of HIV-related tuberculosis
    William J Burman
    Denver Public Health and the Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver, CO, USA
    Semin Respir Infect 18:263-71. 2003
  3. ncbi request reprint The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life
    William J Burman
    Denver Public Health Department and the Department of Medicine, University of Colorado Health Sciences Center, Denver, CO, USA
    J Acquir Immune Defic Syndr 47:185-93. 2008
  4. pmc Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial
    William Burman
    Denver Public Health, 605 Bannock Street, Denver, CO 80204, USA
    J Acquir Immune Defic Syndr 49:142-50. 2008
  5. ncbi request reprint Issues in the management of HIV-related tuberculosis
    William J Burman
    Division of Infectious Diseases, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA
    Clin Chest Med 26:283-94, vi-vii. 2005
  6. ncbi request reprint Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis
    William Burman
    Denver Public Health, Denver, CO 80204, USA
    Am J Respir Crit Care Med 173:350-6. 2006
  7. pmc Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens
    William J Burman
    PLoS Med 5:e176. 2008
  8. ncbi request reprint Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis
    William J Burman
    Denver Public Health and the Department of Medicine, University of Colorado Health Sciences National Jewish Medical and Research Center, Denver, Colorado, USA
    Am J Respir Crit Care Med 174:331-8. 2006
  9. ncbi request reprint Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis
    W Burman
    Denver Public Health and the University of Colorado Health Sciences Center, Denver, Colorado 80204, USA
    Int J Tuberc Lung Dis 11:1282-9. 2007
  10. ncbi request reprint Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates
    William J Burman
    Department of Public Health, Denver Health and Hospital Authority, Colorado 80204, USA
    Am J Med 115:358-64. 2003

Detail Information

Publications45

  1. ncbi request reprint The effects of local review on informed consent documents from a multicenter clinical trials consortium
    William Burman
    Denver Public Health, 605 Bannock Street, Denver, CO 80204, USA
    Control Clin Trials 24:245-55. 2003
    ..Local approval of two multicenter clinical trials was time-consuming and resulted in many changes in centrally approved consent forms. These changes frequently decreased readability and introduced errors...
  2. ncbi request reprint Clinical and radiographic features of HIV-related tuberculosis
    William J Burman
    Denver Public Health and the Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver, CO, USA
    Semin Respir Infect 18:263-71. 2003
    ....
  3. ncbi request reprint The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life
    William J Burman
    Denver Public Health Department and the Department of Medicine, University of Colorado Health Sciences Center, Denver, CO, USA
    J Acquir Immune Defic Syndr 47:185-93. 2008
    ..To evaluate the effect of episodic antiretroviral therapy on quality of life (QOL)...
  4. pmc Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial
    William Burman
    Denver Public Health, 605 Bannock Street, Denver, CO 80204, USA
    J Acquir Immune Defic Syndr 49:142-50. 2008
    ..To compare the HIV transmission risk among patients randomized to episodic versus continuous antiretroviral therapy...
  5. ncbi request reprint Issues in the management of HIV-related tuberculosis
    William J Burman
    Division of Infectious Diseases, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA
    Clin Chest Med 26:283-94, vi-vii. 2005
    ..The author reviews these controversies and makes recommendations for the management of HIV-related tuberculosis...
  6. ncbi request reprint Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis
    William Burman
    Denver Public Health, Denver, CO 80204, USA
    Am J Respir Crit Care Med 173:350-6. 2006
    ..Rifabutin was recommended in place of rifampin during treatment of HIV-related tuberculosis (TB) to facilitate concomitant potent antiretroviral therapy, but this approach has not been evaluated in a prospective study...
  7. pmc Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens
    William J Burman
    PLoS Med 5:e176. 2008
  8. ncbi request reprint Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis
    William J Burman
    Denver Public Health and the Department of Medicine, University of Colorado Health Sciences National Jewish Medical and Research Center, Denver, Colorado, USA
    Am J Respir Crit Care Med 174:331-8. 2006
    ..Moxifloxacin has promising preclinical activity against Mycobacterium tuberculosis, but has not been evaluated in multidrug treatment of tuberculosis in humans...
  9. ncbi request reprint Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis
    W Burman
    Denver Public Health and the University of Colorado Health Sciences Center, Denver, Colorado 80204, USA
    Int J Tuberc Lung Dis 11:1282-9. 2007
    ..Patients were enrolled in a prospective trial of rifabutin-based tuberculosis (TB) treatment for human immunodeficiency virus related TB. Antiretroviral therapy (ART) was encouraged, but not required...
  10. ncbi request reprint Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates
    William J Burman
    Department of Public Health, Denver Health and Hospital Authority, Colorado 80204, USA
    Am J Med 115:358-64. 2003
    ..We evaluated the epidemiology of trimethoprim-sulfamethoxazole-resistant E. coli in a large, public health care system in Denver, Colorado...
  11. pmc Relapse associated with active disease caused by Beijing strain of Mycobacterium tuberculosis
    William J Burman
    Infectious Disease Clinic, Denver Public Health, Denver, Colorado 80204, USA
    Emerg Infect Dis 15:1061-7. 2009
    ..1-108, p = 0.04). Active disease caused by a Beijing strain was associated with increased risk for relapse, particularly among Asian-Pacific Islanders...
  12. ncbi request reprint Lack of toxicity from concomitant directly observed disulfiram and isoniazid-containing therapy for active tuberculosis
    W J Burman
    Denver Public Health Department, Colorado 80204, USA
    Int J Tuberc Lung Dis 6:839-42. 2002
    ..However, the small number of patients on disulfiram limits the strength of this negative finding...
  13. ncbi request reprint Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials
    W J Burman
    Department of Public Health, Denver Health and Hospital Authority, University of Colorado Health Sciences Center, USA
    Clin Pharmacokinet 40:327-41. 2001
    ..Rifabutin toxicity is related to dose and concomitant use of CYP3A inhibitors. The rifamycins illustrate the complexity of predicting the pharmacodynamics of treatment of an intracellular pathogen with the capacity for dormancy...
  14. doi request reprint Rip Van Winkle wakes up: development of tuberculosis treatment in the 21st century
    William J Burman
    Infectious Diseases Clinic of Denver Public Health and Division of Infectious Diseases, University of Colorado, Denver, USA
    Clin Infect Dis 50:S165-72. 2010
    ..Novel drugs, such as TMC207, OPC-67683, PA824, SQ109, and PNU-100480, may improve the treatment of drug-resistant and drug-susceptible tuberculosis...
  15. ncbi request reprint Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment
    W J Burman
    Department of Public Health, Denver Health and Hospital Authority, CO, USA
    Clin Infect Dis 31:1390-5. 2000
    ..Laboratories and tuberculosis control programs should develop procedures to identify patients having only 1 positive culture. Such patients should be further evaluated for the possibility of a false-positive culture...
  16. ncbi request reprint Breaking the camel's back: multicenter clinical trials and local institutional review boards
    W J Burman
    Denver Public Health, 605 Bannock Street, Denver, CO 80204, USA
    Ann Intern Med 134:152-7. 2001
    ..Instead of rigid enforcement of outmoded regulations that do not contribute to patient safety, the responsibilities of the local IRB in the oversight of multicenter clinical trials must be systematically evaluated...
  17. ncbi request reprint Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection
    Debra A Benator
    Division of Infectious Diseases, Veterans Affairs Medical Center, Washington, D C 20422, USA
    Pharmacotherapy 27:793-800. 2007
    ..To characterize the bidirectional interaction between twice-daily nelfinavir and twice-weekly rifabutin and isoniazid in patients with tuberculosis and human immunodeficiency virus (HIV) infection...
  18. ncbi request reprint CD4+ count-guided interruption of antiretroviral treatment
    W M El-Sadr
    Division of Infectious Diseases, Harlem Hospital Center and Columbia University, New York, NY 10037, USA
    N Engl J Med 355:2283-96. 2006
    ..Despite declines in morbidity and mortality with the use of combination antiretroviral therapy, its effectiveness is limited by adverse events, problems with adherence, and resistance of the human immunodeficiency virus (HIV)...
  19. pmc Durability of adherence to antiretroviral therapy on initial and subsequent regimens
    Edward M Gardner
    Denver Public Health, 605 Bannock Street, MC 2600, Denver, Colorado 80204, USA
    AIDS Patient Care STDS 20:628-36. 2006
    ..Adherence decreases during an initial regimen and on sequential antiretroviral regimens. Effective and durable interventions to prevent declining adherence are needed...
  20. doi request reprint Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates
    Luke Johnson
    University of Denver and Department of Patient Safety and Quality, Denver Health and Hospital Authority, Denver, Colo, USA
    Am J Med 121:876-84. 2008
    ..We evaluated the effects of that switch 6 years later...
  21. pmc Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance
    Edward M Gardner
    Denver Public Health, Denver, Colorado 80204, USA
    AIDS 22:75-82. 2008
    ..To investigate the occurrence of differential adherence to components of combination antiretroviral therapy and assess its predictors and association with virological failure and antiretroviral medication resistance...
  22. doi request reprint Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia
    Timothy C Jenkins
    Division of Infectious Diseases, Denver Health and Hospital Authority, Colorado, USA
    Clin Infect Dis 46:1000-8. 2008
    ..Staphylococcus aureus bacteremia causes considerable morbidity and mortality, and strategies to improve management and outcomes of this disease are needed...
  23. pmc The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection
    Edward M Gardner
    Denver Public Health, Denver, Colorado, USA
    Clin Infect Dis 52:793-800. 2011
    ....
  24. ncbi request reprint Selective drug taking during combination antiretroviral therapy in an unselected clinic population
    Edward M Gardner
    University of Colorado Health Sciences Center, Denver, CO 80204, USA
    J Acquir Immune Defic Syndr 40:294-300. 2005
    ..Multidrug therapy is necessary to achieve sustained viral suppression. Discordant adherence to individual components of a multidrug regimen may lead to adverse outcomes...
  25. doi request reprint Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship
    Timothy C Jenkins
    Department of Medicine and Division of Infectious Diseases, Denver Health Medical Center, University of Colorado Denver, Denver, CO, USA
    Clin Infect Dis 51:895-903. 2010
    ..Although complicated skin and soft-tissue infections (SSTIs) are among the most common infections requiring hospitalization, their clinical spectrum, management, and outcomes have not been well described...
  26. pmc The association of adherence to antiretroviral therapy with healthcare utilization and costs for medical care
    Edward M Gardner
    Denver Public Health, Denver, Colorado, USA
    Appl Health Econ Health Policy 6:145-55. 2008
    ..The association between antiretroviral adherence, healthcare utilization and medical costs has not been well studied...
  27. pmc Skin-test screening and tuberculosis transmission among the homeless
    Po Marn Kong
    Denver Public Health, Denver, Colorado, USA
    Emerg Infect Dis 8:1280-4. 2002
    ..03). Our results suggest that the shelter-based screening program decreased the incidence of TB by decreasing its transmission among the homeless...
  28. doi request reprint Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals
    Timothy C Jenkins
    Division of Infectious Diseases, Denver Health, CO 80204, USA
    Infect Control Hosp Epidemiol 30:233-41. 2009
    ..To describe the epidemiology of bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus (MRSA), which are traditionally associated with cases of community-acquired infection, in the healthcare setting...
  29. pmc Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trial
    Edward M Gardner
    Denver Public Health, 605 Bannock Street, Denver, CO 80204, USA
    AIDS 24:395-403. 2010
    ..To assess the association between adherence to antiretroviral therapy and the presence of class-specific antiretroviral medication resistance...
  30. ncbi request reprint Widespread emergence of methicillin resistance in community-acquired Staphylococcus aureus infections in Denver
    Megan J Clancy
    Department of Internal Medicine, University of Colorado Health Sciences Center, Denver, CO USA
    South Med J 98:1069-75. 2005
    ..Increasing rates of methicillin resistance among out-patient Staphylococcus aureus infections led us to assess the epidemiology and outcome of a local outbreak...
  31. ncbi request reprint HIV transmission risk behavior and its relation to antiretroviral treatment adherence
    Rachel C Flaks
    Department of Public Health, Denver Health and Hospital Authority, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Sex Transm Dis 30:399-404. 2003
    ..Rising rates of antiretroviral drug resistance among recently infected persons are evidence of high-risk behavior among persons in HIV care...
  32. ncbi request reprint Population pharmacokinetic modeling of pyrazinamide in children and adults with tuberculosis
    Min Zhu
    Department of Medicine, National Jewish Medical and Research Center, Denver, CO 80206, USA
    Pharmacotherapy 22:686-95. 2002
    ..To determine population pharmacokinetic parameters of pyrazinamide after multiple oral doses given to children and adults with tuberculosis...
  33. ncbi request reprint Conventional and molecular epidemiology of macrolide resistance among new Mycobacterium avium complex isolates recovered from HIV-infected patients
    Edward M Gardner
    Denver Public Health, Department of Medicine, Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver 80204, USA
    Clin Infect Dis 41:1041-4. 2005
    ..Initial MAC isolates in HIV-infected persons should routinely be tested for macrolide resistance...
  34. ncbi request reprint Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients
    P Kazanjian
    Division of Infectious Diseases, Dept of Medicine, University of Michigan Health System, Ann Arbor, MI 48109 0378, USA
    J Infect Dis 182:551-7. 2000
    ..1; P=0.01). Thus, an increased duration of sulfa or sulfone prophylaxis increases the chance of developing a P. carinii mutation. The majority of patients with mutations respond to sulfa or sulfone therapy...
  35. ncbi request reprint Risk-based human immunodeficiency virus (HIV) testing fails to detect the majority of HIV-infected persons in medical care Settings
    Timothy C Jenkins
    Denver Public Health, Denver, Colorado 80204, USA
    Sex Transm Dis 33:329-33. 2006
    ..To evaluate opportunities for earlier human immunodeficiency virus (HIV) diagnosis within a comprehensive public health care system...
  36. ncbi request reprint Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome
    Helen McIlleron
    Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa
    J Infect Dis 196:S63-75. 2007
    ..These complexities of coadministration of antitubercular and antiretroviral agents are reviewed, and research priorities are highlighted...
  37. ncbi request reprint American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis
    Henry M Blumberg
    Am J Respir Crit Care Med 167:603-62. 2003
  38. ncbi request reprint The hunt for the elusive surrogate marker of sterilizing activity in tuberculosis treatment
    William J Burman
    Am J Respir Crit Care Med 167:1299-301. 2003
  39. ncbi request reprint Recurrent tuberculosis in the United States and Canada: relapse or reinfection?
    Robert M Jasmer
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA
    Am J Respir Crit Care Med 170:1360-6. 2004
    ..We conclude that recurrent tuberculosis in the United States and Canada, countries with low rates of tuberculosis, is rarely due to reinfection with a new strain of M. tuberculosis...
  40. ncbi request reprint Grade 4 events are as important as AIDS events in the era of HAART
    Ronald B Reisler
    Institute of Human Virology, University of Maryland, Baltimore, MD 21201, USA
    J Acquir Immune Defic Syndr 34:379-86. 2003
    ....
  41. ncbi request reprint Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy
    Marc Weiner
    Department of Medicine, South Texas Veterans Health Care System, San Antonio, Texas 78229, USA
    Am J Respir Crit Care Med 169:1191-7. 2004
    ..The present pharmacokinetic study supports further trials to determine the optimal rifapentine dose for treatment of tuberculosis...
  42. ncbi request reprint How much directly observed therapy is enough?
    William J Burman
    Am J Respir Crit Care Med 170:474-5. 2004
  43. ncbi request reprint Short-course regimens for latent tuberculosis: what is ready for prime time?
    William J Burman
    Enferm Infecc Microbiol Clin 25:297-9. 2007
  44. ncbi request reprint Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial
    Andrew N Phillips
    Department of Primary Care and Population Sciences, Royal Free University College Medical School, London, UK
    Antivir Ther 13:177-87. 2008
    ..Exploratory analyses were performed to better understand the reasons for this observation...
  45. ncbi request reprint Tuberculosis in patients with HIV infection
    Peter F Barnes
    Center for Pulmonary and Infectious Disease Control, Departments of Medicine, Microbiology and Immunology, University of Texas Health Center, Tyler, Texas, USA
    Infect Dis Clin North Am 16:107-26. 2002
    ..New guidelines are available for the treatment of active and latent TB infection in patients with HIV...